ENDRA LIFE SCIENCES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
ENDRA LIFE SCIENCES INC. (NDRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 114.85 thousand shares for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2021-08-12
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2021-06-30 was 104.96K shares, a 2549.09% increase year-over-year.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2021-03-31 was 9.89K shares.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-12-31 was 16.67K shares.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-09-30 was 186.90K shares.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2020 was 207.53K shares, a 156.00% increase from fiscal 2019.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2019 was 81.06K shares, a 3953.25% increase from fiscal 2018.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2018 was 2.00K shares, a 86.65% decline from fiscal 2017.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2017 was 14.98K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2021-06-30 | 104.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 114.85K shares 10-Q · filed 2021-08-12 | 131.52K shares derived: sum of 3 quarters · filed 2021-08-12 | 318.42K shares derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | 9.89K shares 10-Q · filed 2021-05-17 | 26.56K shares derived: sum of 2 quarters · filed 2021-05-17 | 213.46K shares derived: sum of 3 quarters · filed 2021-05-17 | 217.43K shares derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-12-31 | 16.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 203.57K shares derived: sum of 2 quarters · filed 2021-03-25 | 207.53K shares derived: sum of 3 quarters · filed 2021-03-25 | 207.53K shares 10-K · filed 2021-03-25 |
| 2020-09-30 | 186.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | 190.86K shares derived: sum of 2 quarters · filed 2020-11-16 | 190.86K shares 10-Q · filed 2020-11-16 | 190.86K shares derived: sum of 4 quarters · filed 2020-11-16 |
| 2020-06-30 | 3.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | 3.96K shares 10-Q · filed 2020-08-14 | 3.96K shares derived: sum of 3 quarters · filed 2020-08-14 | 3.96K shares derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2020-05-14 | 0.00 shares derived: sum of 3 quarters · filed 2020-05-14 | 4.77K shares derived: sum of 4 quarters · filed 2020-05-14 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | 0.00 shares derived: sum of 2 quarters · filed 2020-03-26 | 4.77K shares derived: sum of 3 quarters · filed 2020-03-26 | 81.06K shares 10-K · filed 2020-03-26 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | 4.77K shares derived: sum of 2 quarters · filed 2019-11-13 | 81.06K shares 10-Q · filed 2019-11-13 | 81.06K shares derived: sum of 4 quarters · filed 2019-11-13 |
| 2019-06-30 | 4.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 81.06K shares 10-Q · filed 2019-08-08 | 81.06K shares derived: sum of 3 quarters · filed 2019-08-08 | 81.06K shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | 76.29K shares 10-Q · filed 2019-05-14 | 76.29K shares derived: sum of 2 quarters · filed 2019-05-14 | 76.29K shares derived: sum of 3 quarters · filed 2019-05-14 | 76.29K shares derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | 0.00 shares derived: sum of 2 quarters · filed 2019-03-11 | 0.00 shares derived: sum of 3 quarters · filed 2019-03-11 | 2.00K shares 10-K · filed 2019-03-11 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | 0.00 shares derived: sum of 2 quarters · filed 2018-11-05 | 2.00K shares 10-Q · filed 2018-11-05 | 2.00K shares derived: sum of 4 quarters · filed 2018-11-05 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | 2.00K shares 10-Q · filed 2018-08-13 | 2.00K shares derived: sum of 3 quarters · filed 2018-08-13 | 2.00K shares derived: sum of 4 quarters · filed 2018-08-13 |
| 2018-03-31 | 2.00K shares 10-Q · filed 2018-05-15 | 2.00K shares derived: sum of 2 quarters · filed 2018-05-15 | 2.00K shares derived: sum of 3 quarters · filed 2018-05-15 | 16.98K shares derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | 0.00 shares derived: sum of 2 quarters · filed 2018-03-20 | 14.98K shares derived: sum of 3 quarters · filed 2018-03-20 | 14.98K shares 10-K · filed 2018-03-20 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 14.98K shares derived: sum of 2 quarters · filed 2017-11-14 | 14.98K shares 10-Q · filed 2017-11-14 | |
| 2017-06-30 | 14.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 14.98K shares 10-Q · filed 2017-08-07 | ||
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |